Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 469Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
LETTER TO EDITOR
Year : 2018  |  Volume : 9  |  Issue : 4  |  Page : 187-188

From “Glivec®” to “Prevnar 13®”: How strong is the Indian drug patenting system?


Department of Pharmacology, Sri Venkateshwaraa Medical College Hospital and Research Centre, Puducherry, India

Correspondence Address:
Dr. Gerard Marshall Raj
Department of Pharmacology, Sri Venkateshwaraa Medical College Hospital and Research Centre, Puducherry - 605 102
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/picr.PICR_102_18

Rights and Permissions



[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed324    
    Printed9    
    Emailed0    
    PDF Downloaded66    
    Comments [Add]    

Recommend this journal